Stephanie Alband
MSBA
23 March/MC | ENETS/INCA Symposium | Speaker
- patient participation in improving clinical care and collaborating in research
Valentina Ambrosini
Associate Professor, PhD
22 March/PG | Session A | Speaker
- PET/CT in NEN
- PET/CT with FDG and non-FDG radiopharmaceuticals
- PET/CT in oncology
Christoph J. Auernhammer
Professor
24 March/MC | Session 5A | Speaker
- Neuroendocrine tumors - targeted therapy and epigenetic modulation
Detlef Bartsch
Dr. med.
22 March/PG | Session B | Speaker
- Surgery of small intestine NEN and pNEN
- Surgery of anaplastic thyroid cancer
Eric Baudin
MD, PhD
22 March/PG | Moderator
23 March/MC | Session 1 | Speaker
23 March/MC | Session 4C | Moderator
- Endocrine tumors
Philip Bischoff
Dr. med.
22 March/BS | Session 1 | Speaker
- Single-cell sequencing
- Lung tumors
- Tumor microenvironment
Mette Borre
RD
24 March/MC | Nurse Symposium | Speaker
- Neuroendocrine cancer
- Nutrition
- Quality of life for my patients
Catherine Bouvier Ellis
23 March/MC | ENETS/INCA Symposium | Speaker
- Neuroendocrine Cancers
- Education
- Advocacy
Jaume Capdevila
MD, PhD
22 March/BS | Session 4 | Moderator
23 March/MC | Session 4C | Speaker
Martyn Caplin
PROFESSOR
22 March/PG | Session A | Speaker
- Translational Neuroendocrine Tumour Research - mesenetric fibrosis/desmoplasia
- Peptide receptor expression in NETs
- Peptide Receptor Radioligand Therapy
Damiano Caruso
MD, PhD
23 March/MC | Session 3A | Speaker
- Radiomics
- Artificial Intelligence
- Oncology
Justo P. Castaño
Bs, MSc, PhD
22 March/BS | Moderator
22 March/BS | Session 1 | Moderator
22 March/BS | Session 2 | Speaker
- Deciphering the role of splicing and RNA biology in Pancreatic, GI and Lung NETs
- Somatostatin and its receptors in NETs
Yasmin Chotai de Lima
24 March/MC | Nurse Symposium | Moderator
- Interested in nutrition and NETs. Currently working on collaboration with other Specialist Dietitians producing guidance on nutrition and NETs.
Dominique Clement
MD
22 March/PG | Session C | Speaker
24 March/MC | Nurse Syposium | Speaker
- PhD student, thesis title the nutritional status of patients with GEP-NETs
Christian Conrad
Prof.
22 March/BS | Session 1 | Speaker
- Single cell technologies
- Microscopic Screening
- Neural Network Learning
Anne Couvelard
MD, PhD
22 March/BS | Moderator
22 March/BS | Session 2 | Moderator
- Pathological and molecular characteristics of high grade neuroendocrine neoplasms
- Molecular heterogeneity of neuroendocrine neoplasms
- Diagnostic, prognostic and theranostic biomarkers in neuroendocrine neoplasms
Joakim Crona
MD PhD
22 March/BS | Session 3 | Moderator
- Neuroendocrine tumors
Jérôme Cros
Pr
22 March/BS | Session 3 | Speaker
- Neuroendocrine tumor molecular heterogeneity
- Biomarkers
Wouter W. De Herder
MD PhD
23 March/MC | Session 1 | Speaker
- Fibrosis and NET
- PRRT
- Therapy of NET
Christophe Deroose
M.D, Ph.D.
22 March/PG | Session D | Panelist
23 March/MC | Session 2A | Moderator
- PRRT
- Somatostatin receptor PET
- MFBG PET
Frederic Deschamps
MD, PhD
23 March/MC | Session 4C | Speaker
- Interventional radiology
- Trans-arterial chemoembolization
- bone metastases
Anne-Marie Dingemans
MD PhD
23 March/MC | Session 4C Moderator & Speaker
- Neuro-endocrine tumors of the lung
- Driver mutations
- Oligometastatic disease
Clarisse Dromain
Full Professor
22 March/PG | Session A | Speaker
- Imaging of neuroendocrine tumor
Sugandha Dureja
Dr
23 March/MC | ENETS/INCA Symposium | Speaker
- Theranostics for NETs and Prostate cancer
- Ac 225 Alpha therapy for advanced NETs
- Ga68- FAPI based imaging and therapy- exploring their role in Phaeochromocytomas/Paragangliomas
Antongiulio Faggiano
MD, PhD
22March/PG | Session D | Speaker
- Molecular mechanisms of disease progression in NEN: NGS analysis of blood samples
- Clinical study on therapy with somatostatin analogues in NEN and sequence of treatments
- Clinical study on quality of life in NEN (endocrine-metabolic profile, nutrition, psyschological aspects)
Massimo Falconi
Prof.
23 March/MC | Session 3B | Moderator
- Pancreatic surgery
- Neuroendocrine GEP NEN
- Pancreatic ductal adenocarcinoma
Nicola Fazio
M.D., Ph.D.
22 March/PG | Session B | Speaker
23 March/MC | Session 2A | Moderator
- Neuroendocrine neoplasms
- Upper GI cancers
- Hepato-pancreato-biliary cancers
Lynnette Fernandez-Cuesta
PhD
22 March/BS | Session 1 | Speaker
- Rare Cancers Genomics initiative (www.rarecancersgenomics.com)
- Neuroendocrine tumors (lungNENomics project)
- Mesothelioma (MESOMICS project)
Pier Luigi Filosso
Prof.
23 March/MC | Session 4C | Speaker
- Thoracic Surgery
- Surgical management of Lung and Thymic Neuroendocrine tumors
Melissa Frizziero
MD
23 March/MC | Session 4A | Speaker
- Studying epigenetic changes occurring along Pancreatic Neuroendocrine Tumor progression
- Establishing an in vitro model of PanNET for precision medicine
Rocio Garcia-Carbonero
MD, PhD
22 March/PG | Session D | Moderator
23 March/MC | ENETS/INCA Symposium | Speaker
23 March/MC | Session 3B | Moderator
- New drug development in NETs and NECs
- Development of biomarkers in NENs
- Translational research
Wanda Geilvoet
24 March/MC | Nurse Symposium | Moderator
- Outpatient clinic for patients with neuroendocrine tumors and other endocrine cancers, patient coordinator and contact person in ENETS CoE
- Active member tumor board for endocrine tumors and closely involved with the ENETS Center of Excellence audits
- Vice-chair of ENETS Nurse & Dietician Group and member of medical advisory panel INCA
Simona Glasberg
Professor
23 March/MC | Session 1 | Speaker
- Enhancers and neuroendocrine neoplasms
- The role of cannabinoids in neuroendocrine neoplasms
- Autophagy and neuroendocrine neoplasms
Enrique Grande
MD
22 March/PG | Session B | Speaker
- Biomarkers
- Wearable devices and health
- Artificial intelligence
Julien Hadoux
MD, PhD
22 March/PG | Session C | Speaker
- Neuroendocrine carcinoma
- Precision medicine
- Anaplastic thyroid carcinoma
Daniel M. Halperin
MD
24 March/MC | Session 5A | Speaker
Hans Hofland
22 March/PG | Session C | Speaker
24 March/MC | Session 5C | Moderator
- Functional NET syndromes
- Radionuclide therapy
Frediano Inzani
MD, PhD
23 March/MC | LAA | Laudator
- Neuroendocrine neoplasms
- Gynecologic Pathology
- Pancreatic cancer
Gregory Kaltsas
Professor
22 March/PG | Session C | Speaker
22 March/PG | Session D | Speaker
- Inherited Endocrine Syndromes
- Bone metastases in neuroendocrine tumors
- Gastric Neuroendocrine neoplasms
Andreas Kjaer
MD, PhD
23 March/MC | Session 2A | Speaker
- Molecular imaging of neuroendocrine tumors
- Theranostics and targeted radionuclide therapy in NET
Ulrich Knigge
MD, DMSc
22 March/PG | Session D | Panelist
- Small initestinal NET
- Appendiceal NET
- Neuroendocrine carcinomas and NET G3
Teodora Kolarova
23 March/MC | ENETS/INCA Symposium | Speaker
Beata Kos-Kudła
MD, PhD, Prof.
22 March/PG | Session A | Moderator
22 March/PG | Session D | Panelist
- Biomarkers inNET
- Diagnosis and treatment of GEP NET
- Lung NET
Anna Koumarianou
MD PhD
22 March/PG | Session B | Speaker
- Lung Neuroendocrine Tumors
- miRNA biomarkers
- Clinical Trials in high-grade tumors
Stefano La Rosa
Prof.
22 March/BS | Session 1 | Moderator
23 March/MC | Session 4A | Speaker
Erin Laing
PhD
24 March/MC | Nurse Symposium | Speaker
- Development of a NET-nutrition screening tool for patients with NETs requiring dietitian referral and nutrition support
- Understanding nutrition-related symptoms, complications and quality of life in patients with gastrointestinal NETs
Angela Lamarca
MD, PhD, MSc
23 March/MC | Session 3A | Speaker
- Systemic treatment for NENs
- Development of predictive and prognostic biomarkers in NENs
- Management of carcinoid syndrome and associated complications
Rita Lawlor
PhD
22 March/BS | Session 4 | Speaker
- neuroendcrine tumors of the pancreas
- molecular pathology
Côme Lepage
Pr
24 March/MC | Session 6A | Speaker
- Epidemiology of digestive cancers
- Clinical research in digestive oncology
- NET
Ilaria Marinoni
22 March/BS | Session 3 | Speaker
- Studying epigenetic changes occurring along Pancreatic Neuroendocrine Tumor progression.
- Establishing an in vitro model of PanNET for precision medicine
Wendy Martin
MSc, BSc (hons), RGN
22 March/PG | Session D | Panelist
24 March/MC | Nurse Symposium | Speaker
- Quality of Life
- Carcinoid heart disease
- Education
Marius Mayerhoefer
MD, PHD
23 March/MC | Session 3A | Moderator
- Hybrid imaging
- Radiomics and artificial intelligence
- Neuroendocrine and hematological malignancies
Mark McDonnell
Mr
23 March/MC | ENETS/INCA Symposium | Moderator
- Patient advocacy and engagement
- Treatment options
- Patient pathway
Els Nieveen van Dijkum
Prof Dr
22 March/PG | Session B | Moderator
24 March/MC | Session 6A | Speaker
- Pancreatic NET - Risk stratification for recurrence, wait and see in small pNET, surgical outcomes and Quality of Life
- Small bowel NET - Surgical approach, fluorescence, treatment planning
- Training and education - Training residents and surgeons, nurses and patients
Dermot O'Toole
MD
23 March/MC | ENETS/INCA Symposium | Speaker
- Digestive neuroendocrine tumours
- Barrett's oesophagus (Dx and treatment)
- Familial pancreatic cancer
Kjell Öberg
MD.PhD. Professor
22 March/PG | Session C | Moderator
- Biomarkers in NET
- Immunotherapy
- Radiotherapy
Francesco Panzuto
MD, PhD
22 March/PG | Session D | Panelist & Speaker
23 March/MC | Session 1 | Moderator
- Gastric Neuroendocrine Neoplasia
- NEN epidemiology (national registry - database)
- Prognostic features and risk factros for NEN progression
Stefano Partelli
Prof
24 March/MC | Session 7 | Speaker
- Surgical treatment of GEP-NEN
- Management of asymptomatic small Pan-NET
- Preoperative therapy for advanced GEP-NEN
Marianne Pavel
Prof. Dr.
22 March/PG | Session B | Moderator
24 March/MC | Session 5A | Moderator & Speaker
- Precision oncology in NEN
- Novel targeted treatment in NEN
- High grade NEC
Aurel Perren
Prof
22 March/PG | Session A | Speaker
24 March/MC | Session 6B | Moderator
- The role of epigenetics and metabolism in the progression of Pancreatic Neuroendocrine Tumors (PanNET)
- Tumoroids / Organoids as models for PanNET
- Pathological and molecular classification of endocrine tumors
Deborah Pitfield
24 March/MC | Nurse Symposium | Speaker
- NET
John Ramage
Professor
22 March/PG | Session A | Moderator
24 March/MC | Session 6A | Moderator
- Quality of life and symptoms scores in neuroendocrine tumours of the small bowel and liver
- Rectal NET endoscopic therapy
- UK NET registry data epidemiology
Nicholas Reed
Prof.
24 March/MC | Session 5C | Moderator
24 March/MC | Session 7 | Speaker
- PRRT,
- New chemotherapy/medical treatments
- New treatment approaches
Guido Rindi
M.D., Ph.D
22 March/BS | Session 3 |Moderator
23 March/MC | LAA | Recipient
- NEN
- GI
- Lung
Anja Rinke
PD Dr
22 March/PG | Session A | Speaker
22 March/PG | Session C | Moderator
- GEP NEN, clinical trials, prognostic parameters
- Lung NETs
Philippe Ruszniewski
Prof
24 March/MC | Session 5A | Moderator
- NET epidemiology
- NET treatment
- Translational medicine
Bruno Sainz Anding
PhD
22 March/BS | Session 2 | Speaker
- Cancer Stem Cells
- Pancreatic Cancer
- Tumor Fibroinflammatory Microenvironment
Camilla Schalin-Jantti
Adj. Prof., M.D, Ph.D
23 March/MC | Session 1 | Speaker
- Neuroendocrine tumours
- Parathyroid carcinoma
- MEN1
Simron Singh
Dr
23 March/MC | ENETS/INCA Symposium | Speaker
- Clinical Trials
- Patient Centered Care
- Health Services Reserach
Halfdan Sorbye
Prof
22 March/BS | Session 4 | Speaker
23 March/MC | Session 4A & B | Moderator
- Gastroenteropancreatic neuroendocrine carcinoma
Francesca Spada
M.D., Ph.D
23 March/MC | Session 4A | Speaker
- Management and development of predictive and prognostic biomarkers in high grade NENs and mixed NENs
- Chemotherapy in NENs
- Management of functioning NETs
Raj Srirajaskanthan
Dr
23 March/MC | Session 6A | Speaker
- Epidemiology and prognosis of Neuroendocrine Neoplasms
- Endoscopic characterisation of resection of NETs
- Ex-vivo models of NETs
Anders Sundin
MD PhD Prof
23 March/MC | Session 3A | Moderator
- PET/CT, PET/MRI and SPECT/CT in neuroendocrine and endocrine tumors • 68Ga-DOTATOC-PET/MRI
- Pheochromocytama and paraganglioma
- Optimization of PRRT
Margot Tesselaar
MD PhD
22 March/PG | Session D | Panelist
- Carcinoid heart disease
- Immunotherapy/chemotherapy
- NEC/MCC
Chrissie Thirlwell
MD PhD
22 March/BS | Session 3 | Speaker
24 March/MC | Session 6B | Moderator
- Integrated genomic analysis of neuroendocrine neoplasms
- Epigenetics - DNA methylation
- Molecular classification of neuroendocrine neoplasms
Eva Tiensuu Janson
MD PhD
22 March/BS | Session 4 | Moderator
23 March/MC | ENETS/INCA Symposium | Moderator
23 March/MC | Session 7 | Moderator
- Small intestinal NETS
- Neuroendocrine carcinomas
- Genetics
Christos Toumpanakis
Prof, MD, PhD, FRCP, AGAF, FEBGH
22 March/PG | Moderator
22 March/PG | Session D | Moderator & Speaker
- Carcinoid Heart Disease
- Novel blood and imaging biomarkers
- Mesenteric fibrosis
Marie-Louise van Velthuysen
MD, PhD
22 March/PG | Session D | Panelist
23 March/MC | Session 4A & B | Moderator
- Classification of NEN G3
- Appendiceal Neoplasms
Thomas Walter
PhD, MD
24 March/MC | Session 6A | Moderator
- Systemic treatments of NEN
- Leading some clinical trials (NIPINEC, BEVANEC, MGMT-NET...)
- Metastatic lung carcinoid tumors
Staffan Welin
MD,PhD
22 March/PG | Session A | Speaker
23 March/MC | Session 1 | Moderator
- PRRT
- GEPNETS
- MEN1
Bertram Wiedenmann
Prof. Dr. med.
22 March/BS | Session 2 | Moderator
- Molecular profiling of NET entity subgroups
- Clinical trials
- Tumor and cell biology
Damian Wild
MD, PhD
24 March/MC | Session 5A | Speaker
- Molecular imaging with PET/CT
- Targeted radionuclide therapy including peptide receptor radionuclide therapy
- Neuroendocrine tumors